0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global At-Home Drug of Abuse (DOA) Testing Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-32I2193
Home | Market Reports | Health| Nursing
Global At Home Drug of Abuse DOA Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Global At-Home Drug of Abuse (DOA) Testing Market Research Report 2025

Code: QYRE-Auto-32I2193
Report
September 2025
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

At-Home Drug of Abuse (DOA) Testing Market Size

The global market for At-Home Drug of Abuse (DOA) Testing was valued at US$ 516 million in the year 2024 and is projected to reach a revised size of US$ 1035 million by 2031, growing at a CAGR of 10.6% during the forecast period.

At-Home Drug of Abuse (DOA) Testing Market

At-Home Drug of Abuse (DOA) Testing Market

The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.
The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
This report aims to provide a comprehensive presentation of the global market for At-Home Drug of Abuse (DOA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding At-Home Drug of Abuse (DOA) Testing.
The At-Home Drug of Abuse (DOA) Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global At-Home Drug of Abuse (DOA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the At-Home Drug of Abuse (DOA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of At-Home Drug of Abuse (DOA) Testing Market Report

Report Metric Details
Report Name At-Home Drug of Abuse (DOA) Testing Market
Accounted market size in year US$ 516 million
Forecasted market size in 2031 US$ 1035 million
CAGR 10.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Test Cups
  • Test Dip Cards
  • Test Strips
  • Others
Segment by Application
  • Urine
  • Saliva
  • Hair
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company UCP Biosciences, Orient New Life Medical, Express Diagnostics Int’l, Assure Tech (Hangzhou), Psychemedics Corporation, Confirm BioSciences, Phamatech, Home Health (U.K.) Ltd., Quest Products
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of At-Home Drug of Abuse (DOA) Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is At-Home Drug of Abuse (DOA) Testing Market growing?

Ans: The At-Home Drug of Abuse (DOA) Testing Market witnessing a CAGR of 10.6% during the forecast period 2025-2031.

What is the At-Home Drug of Abuse (DOA) Testing Market size in 2031?

Ans: The At-Home Drug of Abuse (DOA) Testing Market size in 2031 will be US$ 1035 million.

Who are the main players in the At-Home Drug of Abuse (DOA) Testing Market report?

Ans: The main players in the At-Home Drug of Abuse (DOA) Testing Market are UCP Biosciences, Orient New Life Medical, Express Diagnostics Int’l, Assure Tech (Hangzhou), Psychemedics Corporation, Confirm BioSciences, Phamatech, Home Health (U.K.) Ltd., Quest Products

What are the Application segmentation covered in the At-Home Drug of Abuse (DOA) Testing Market report?

Ans: The Applications covered in the At-Home Drug of Abuse (DOA) Testing Market report are Urine, Saliva, Hair, Others

What are the Type segmentation covered in the At-Home Drug of Abuse (DOA) Testing Market report?

Ans: The Types covered in the At-Home Drug of Abuse (DOA) Testing Market report are Test Cups, Test Dip Cards, Test Strips, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Test Cups
1.2.3 Test Dip Cards
1.2.4 Test Strips
1.2.5 Others
1.3 Market by Application
1.3.1 Global At-Home Drug of Abuse (DOA) Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Urine
1.3.3 Saliva
1.3.4 Hair
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global At-Home Drug of Abuse (DOA) Testing Market Perspective (2020-2031)
2.2 Global At-Home Drug of Abuse (DOA) Testing Growth Trends by Region
2.2.1 Global At-Home Drug of Abuse (DOA) Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 At-Home Drug of Abuse (DOA) Testing Historic Market Size by Region (2020-2025)
2.2.3 At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2026-2031)
2.3 At-Home Drug of Abuse (DOA) Testing Market Dynamics
2.3.1 At-Home Drug of Abuse (DOA) Testing Industry Trends
2.3.2 At-Home Drug of Abuse (DOA) Testing Market Drivers
2.3.3 At-Home Drug of Abuse (DOA) Testing Market Challenges
2.3.4 At-Home Drug of Abuse (DOA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue
3.1.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue (2020-2025)
3.1.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2020-2025)
3.2 Global At-Home Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by At-Home Drug of Abuse (DOA) Testing Revenue
3.4 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio
3.4.1 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by At-Home Drug of Abuse (DOA) Testing Revenue in 2024
3.5 Global Key Players of At-Home Drug of Abuse (DOA) Testing Head office and Area Served
3.6 Global Key Players of At-Home Drug of Abuse (DOA) Testing, Product and Application
3.7 Global Key Players of At-Home Drug of Abuse (DOA) Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Type
4.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Type (2020-2025)
4.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2026-2031)
5 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Application
5.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Application (2020-2025)
5.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America At-Home Drug of Abuse (DOA) Testing Market Size (2020-2031)
6.2 North America At-Home Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2020-2025)
6.4 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size (2020-2031)
7.2 Europe At-Home Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2020-2025)
7.4 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size (2020-2031)
8.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size (2020-2031)
9.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2020-2025)
9.4 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size (2020-2031)
10.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 UCP Biosciences
11.1.1 UCP Biosciences Company Details
11.1.2 UCP Biosciences Business Overview
11.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Introduction
11.1.4 UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
11.1.5 UCP Biosciences Recent Development
11.2 Orient New Life Medical
11.2.1 Orient New Life Medical Company Details
11.2.2 Orient New Life Medical Business Overview
11.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Introduction
11.2.4 Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
11.2.5 Orient New Life Medical Recent Development
11.3 Express Diagnostics Int’l
11.3.1 Express Diagnostics Int’l Company Details
11.3.2 Express Diagnostics Int’l Business Overview
11.3.3 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Introduction
11.3.4 Express Diagnostics Int’l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
11.3.5 Express Diagnostics Int’l Recent Development
11.4 Assure Tech (Hangzhou)
11.4.1 Assure Tech (Hangzhou) Company Details
11.4.2 Assure Tech (Hangzhou) Business Overview
11.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Introduction
11.4.4 Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
11.4.5 Assure Tech (Hangzhou) Recent Development
11.5 Psychemedics Corporation
11.5.1 Psychemedics Corporation Company Details
11.5.2 Psychemedics Corporation Business Overview
11.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Introduction
11.5.4 Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
11.5.5 Psychemedics Corporation Recent Development
11.6 Confirm BioSciences
11.6.1 Confirm BioSciences Company Details
11.6.2 Confirm BioSciences Business Overview
11.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Introduction
11.6.4 Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
11.6.5 Confirm BioSciences Recent Development
11.7 Phamatech
11.7.1 Phamatech Company Details
11.7.2 Phamatech Business Overview
11.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Introduction
11.7.4 Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
11.7.5 Phamatech Recent Development
11.8 Home Health (U.K.) Ltd.
11.8.1 Home Health (U.K.) Ltd. Company Details
11.8.2 Home Health (U.K.) Ltd. Business Overview
11.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Introduction
11.8.4 Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
11.8.5 Home Health (U.K.) Ltd. Recent Development
11.9 Quest Products
11.9.1 Quest Products Company Details
11.9.2 Quest Products Business Overview
11.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Introduction
11.9.4 Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
11.9.5 Quest Products Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Test Cups
 Table 3. Key Players of Test Dip Cards
 Table 4. Key Players of Test Strips
 Table 5. Key Players of Others
 Table 6. Global At-Home Drug of Abuse (DOA) Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global At-Home Drug of Abuse (DOA) Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global At-Home Drug of Abuse (DOA) Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global At-Home Drug of Abuse (DOA) Testing Market Share by Region (2020-2025)
 Table 10. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global At-Home Drug of Abuse (DOA) Testing Market Share by Region (2026-2031)
 Table 12. At-Home Drug of Abuse (DOA) Testing Market Trends
 Table 13. At-Home Drug of Abuse (DOA) Testing Market Drivers
 Table 14. At-Home Drug of Abuse (DOA) Testing Market Challenges
 Table 15. At-Home Drug of Abuse (DOA) Testing Market Restraints
 Table 16. Global At-Home Drug of Abuse (DOA) Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global At-Home Drug of Abuse (DOA) Testing Market Share by Players (2020-2025)
 Table 18. Global Top At-Home Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2024)
 Table 19. Ranking of Global Top At-Home Drug of Abuse (DOA) Testing Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by At-Home Drug of Abuse (DOA) Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of At-Home Drug of Abuse (DOA) Testing, Headquarters and Area Served
 Table 22. Global Key Players of At-Home Drug of Abuse (DOA) Testing, Product and Application
 Table 23. Global Key Players of At-Home Drug of Abuse (DOA) Testing, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global At-Home Drug of Abuse (DOA) Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2020-2025)
 Table 27. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2026-2031)
 Table 29. Global At-Home Drug of Abuse (DOA) Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Application (2020-2025)
 Table 31. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Application (2026-2031)
 Table 33. North America At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 48. UCP Biosciences Company Details
 Table 49. UCP Biosciences Business Overview
 Table 50. UCP Biosciences At-Home Drug of Abuse (DOA) Testing Product
 Table 51. UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025) & (US$ Million)
 Table 52. UCP Biosciences Recent Development
 Table 53. Orient New Life Medical Company Details
 Table 54. Orient New Life Medical Business Overview
 Table 55. Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Product
 Table 56. Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025) & (US$ Million)
 Table 57. Orient New Life Medical Recent Development
 Table 58. Express Diagnostics Int’l Company Details
 Table 59. Express Diagnostics Int’l Business Overview
 Table 60. Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Product
 Table 61. Express Diagnostics Int’l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025) & (US$ Million)
 Table 62. Express Diagnostics Int’l Recent Development
 Table 63. Assure Tech (Hangzhou) Company Details
 Table 64. Assure Tech (Hangzhou) Business Overview
 Table 65. Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Product
 Table 66. Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025) & (US$ Million)
 Table 67. Assure Tech (Hangzhou) Recent Development
 Table 68. Psychemedics Corporation Company Details
 Table 69. Psychemedics Corporation Business Overview
 Table 70. Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Product
 Table 71. Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025) & (US$ Million)
 Table 72. Psychemedics Corporation Recent Development
 Table 73. Confirm BioSciences Company Details
 Table 74. Confirm BioSciences Business Overview
 Table 75. Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Product
 Table 76. Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025) & (US$ Million)
 Table 77. Confirm BioSciences Recent Development
 Table 78. Phamatech Company Details
 Table 79. Phamatech Business Overview
 Table 80. Phamatech At-Home Drug of Abuse (DOA) Testing Product
 Table 81. Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025) & (US$ Million)
 Table 82. Phamatech Recent Development
 Table 83. Home Health (U.K.) Ltd. Company Details
 Table 84. Home Health (U.K.) Ltd. Business Overview
 Table 85. Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Product
 Table 86. Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025) & (US$ Million)
 Table 87. Home Health (U.K.) Ltd. Recent Development
 Table 88. Quest Products Company Details
 Table 89. Quest Products Business Overview
 Table 90. Quest Products At-Home Drug of Abuse (DOA) Testing Product
 Table 91. Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2020-2025) & (US$ Million)
 Table 92. Quest Products Recent Development
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. At-Home Drug of Abuse (DOA) Testing Picture
 Figure 2. Global At-Home Drug of Abuse (DOA) Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global At-Home Drug of Abuse (DOA) Testing Market Share by Type: 2024 VS 2031
 Figure 4. Test Cups Features
 Figure 5. Test Dip Cards Features
 Figure 6. Test Strips Features
 Figure 7. Others Features
 Figure 8. Global At-Home Drug of Abuse (DOA) Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global At-Home Drug of Abuse (DOA) Testing Market Share by Application: 2024 VS 2031
 Figure 10. Urine Case Studies
 Figure 11. Saliva Case Studies
 Figure 12. Hair Case Studies
 Figure 13. Others Case Studies
 Figure 14. At-Home Drug of Abuse (DOA) Testing Report Years Considered
 Figure 15. Global At-Home Drug of Abuse (DOA) Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global At-Home Drug of Abuse (DOA) Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global At-Home Drug of Abuse (DOA) Testing Market Share by Region: 2024 VS 2031
 Figure 18. Global At-Home Drug of Abuse (DOA) Testing Market Share by Players in 2024
 Figure 19. Global Top At-Home Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by At-Home Drug of Abuse (DOA) Testing Revenue in 2024
 Figure 21. North America At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America At-Home Drug of Abuse (DOA) Testing Market Share by Country (2020-2031)
 Figure 23. United States At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe At-Home Drug of Abuse (DOA) Testing Market Share by Country (2020-2031)
 Figure 27. Germany At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Region (2020-2031)
 Figure 35. China At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Country (2020-2031)
 Figure 43. Mexico At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Country (2020-2031)
 Figure 47. Turkey At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UCP Biosciences Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
 Figure 51. Orient New Life Medical Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
 Figure 52. Express Diagnostics Int’l Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
 Figure 53. Assure Tech (Hangzhou) Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
 Figure 54. Psychemedics Corporation Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
 Figure 55. Confirm BioSciences Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
 Figure 56. Phamatech Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
 Figure 57. Home Health (U.K.) Ltd. Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
 Figure 58. Quest Products Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India